Tatva Chintan Pharma Chem Ltd (Tatva) emerges from a challenging FY24-25 downcycle with strengthened fundamentals and ...

Tatva Chintan has broken out of a 1.5-year downtrend, both technically and fundamentally, suggesting the start of a new growth cycle, according to SEBI-registered analyst Rajneesh Sharma. At the time ...

Tatva Chintan Pharma Chem Q4 Results Live : Tatva Chintan Pharma Chem declared their Q4 results on 03 May, 2024. The topline decreased by 21.08% & the profit decreased by 43.31% YoY. As compared to ...

Tatva Chintan Pharma Chem Ltd (BOM:543321) reported a 48% year-on-year growth in operating revenue, reaching INR1,235 million. EBITDA saw a significant increase of 298% year-on-year, supported by ...

Tatva Chintan Pharma Chem is listed and trades on the NSE stock exchange. What Is the Stock Symbol for Tatva Chintan Pharma Chem? The stock symbol for Tatva Chintan Pharma Chem is "TATV." Does Tatva ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Oct 06, 2025, 10:49 PM IST Tatva Chintan Pharm - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Sep 27, 2025, 11:18 PM IST Tatva Chintan Pharm - Shareholder Meeting / Postal ...

Shares of Tatva Chintan Pharma Chem fell sharply in Wednesday's trade after announcing the December quarter (Q3 FY23) results. The stock slipped 5.44 per cent to hit a day low of Rs 2,066 over its ...